Fulgent Genetics, Inc.
FLGT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $694,927 | $612,940 | $521,061 | $566,142 |
| - Cash | $117,641 | $87,880 | $67,281 | $55,144 |
| + Debt | $476 | $7,386 | $8,279 | $8,468 |
| Enterprise Value | $577,762 | $532,446 | $462,059 | $519,466 |
| Revenue | $84,069 | $81,803 | $73,463 | $76,214 |
| % Growth | 2.8% | 11.4% | -3.6% | – |
| Gross Profit | $35,512 | $34,435 | $28,346 | $31,849 |
| % Margin | 42.2% | 42.1% | 38.6% | 41.8% |
| EBITDA | -$77 | -$15,448 | -$5,790 | -$9,943 |
| % Margin | -0.1% | -18.9% | -7.9% | -13% |
| Net Income | -$6,608 | -$18,957 | -$11,530 | -$5,888 |
| % Margin | -7.9% | -23.2% | -15.7% | -7.7% |
| EPS Diluted | -0.21 | -0.61 | -0.37 | -0.19 |
| % Growth | 65.6% | -64.9% | -94.7% | – |
| Operating Cash Flow | $11,107 | -$30,171 | -$4,431 | $25,018 |
| Capital Expenditures | -$6,050 | -$6,826 | -$4,718 | -$3,778 |
| Free Cash Flow | $5,057 | -$36,997 | -$9,149 | $21,240 |